
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
NFE2L2 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltration in Brain Lower Grade Glioma: A Pan-Cancer Analysis
Qiang Ju, Xinmei Li, Heng Zhang, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-26
Open Access | Times Cited: 82
Qiang Ju, Xinmei Li, Heng Zhang, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-26
Open Access | Times Cited: 82
Showing 1-25 of 82 citing articles:
Multiomic characterization, immunological and prognostic potential of SMAD3 in pan-cancer and validation in LIHC
Tao Zhou, Dan Dan Zhang, Jiejing jin, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Tao Zhou, Dan Dan Zhang, Jiejing jin, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Pan‐Cancer Analysis of the Prognostic and Immunological Role of HSF1: A Potential Target for Survival and Immunotherapy
Fei Chen, Yumei Fan, Pengxiu Cao, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 66
Fei Chen, Yumei Fan, Pengxiu Cao, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 66
Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures
Xinke Zhang, Ying-Ying Wang, Abdulrahim Gari, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 58
Xinke Zhang, Ying-Ying Wang, Abdulrahim Gari, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 58
N6-Methyladenosine Methylation Regulator RBM15 is a Potential Prognostic Biomarker and Promotes Cell Proliferation in Pancreatic Adenocarcinoma
Zhiying Zhao, Qiang Ju, Jing Ji, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 38
Zhiying Zhao, Qiang Ju, Jing Ji, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 38
Pan-cancer landscape of the RUNX protein family reveals their potential as carcinogenic biomarkers and the mechanisms underlying their action
Shen Pan, Siyu Sun, Bitian Liu, et al.
Journal of Translational Internal Medicine (2022) Vol. 10, Iss. 2, pp. 156-174
Open Access | Times Cited: 37
Shen Pan, Siyu Sun, Bitian Liu, et al.
Journal of Translational Internal Medicine (2022) Vol. 10, Iss. 2, pp. 156-174
Open Access | Times Cited: 37
Propentofylline Improves Thiol-Based Antioxidant Defenses and Limits Lipid Peroxidation following Gliotoxic Injury in the Rat Brainstem
Deborah Eileen Menezes Baliellas, Marcelo P. Barros, Cristina V. Vardaris, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1652-1652
Open Access | Times Cited: 15
Deborah Eileen Menezes Baliellas, Marcelo P. Barros, Cristina V. Vardaris, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1652-1652
Open Access | Times Cited: 15
Ferroptosis‐related gene signature as a prognostic marker for lower‐grade gliomas
Yi Zheng, Qiang Ji, Lei Xie, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 6, pp. 3080-3090
Open Access | Times Cited: 32
Yi Zheng, Qiang Ji, Lei Xie, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 6, pp. 3080-3090
Open Access | Times Cited: 32
Pan-cancer analysis of CDC7 in human tumors: Integrative multi-omics insights and discovery of novel marine-based inhibitors through machine learning and computational approaches
Ahmed Saif, Md. Tarikul Islam, Md. Obayed Raihan, et al.
Computers in Biology and Medicine (2025) Vol. 190, pp. 110044-110044
Closed Access
Ahmed Saif, Md. Tarikul Islam, Md. Obayed Raihan, et al.
Computers in Biology and Medicine (2025) Vol. 190, pp. 110044-110044
Closed Access
Pan-cancer analysis and validation show GTF2E2’s diagnostic, prognostic, and immunological roles in regulating ferroptosis in endometrial cancer
Nie Zhang, Xuejin Qin, Jingjing Liu, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0321983-e0321983
Open Access
Nie Zhang, Xuejin Qin, Jingjing Liu, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0321983-e0321983
Open Access
Pan-cancer analysis reveals immunological and prognostic significance of CCT5 in human tumors
Md. Zabir Ahmed, Md Mohtasim Billah, Jannatul Ferdous, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Md. Zabir Ahmed, Md Mohtasim Billah, Jannatul Ferdous, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma
Zhuohui Chen, Tong Wu, Zhouyi Yan, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 26
Zhuohui Chen, Tong Wu, Zhouyi Yan, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 26
Pan-Cancer Analysis of NOS3 Identifies Its Expression and Clinical Relevance in Gastric Cancer
Dan Zou, Zhi Li, Fei Lv, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 24
Dan Zou, Zhi Li, Fei Lv, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 24
Nephrotoxicity of perfluorooctane sulfonate (PFOS)—effect on transcription and epigenetic factors
Yi Wen, Faizan Rashid, Zeeshan Fazal, et al.
Current Zoology (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 18
Yi Wen, Faizan Rashid, Zeeshan Fazal, et al.
Current Zoology (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 18
A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer
Zhi‐Bin Ke, Qi You, Jiang‐Bo Sun, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 17
Zhi‐Bin Ke, Qi You, Jiang‐Bo Sun, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 17
A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis
Rui Chen, Wantao Wu, Siyu Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Rui Chen, Wantao Wu, Siyu Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Neuroglia Cells Transcriptomic in Brain Development, Aging and Neurodegenerative Diseases
Leonard Radu Pinosanu, Bogdan Căpitănescu, Daniela Glăvan, et al.
Aging and Disease (2022) Vol. 14, Iss. 1, pp. 63-63
Open Access | Times Cited: 17
Leonard Radu Pinosanu, Bogdan Căpitănescu, Daniela Glăvan, et al.
Aging and Disease (2022) Vol. 14, Iss. 1, pp. 63-63
Open Access | Times Cited: 17
Fabrication of Etoposide-loaded superparamagnetic iron oxide nanoparticles (SPIONs) induced apoptosis in glioma cancer cells
Zhihua Wang, Ye Wang, Hailiang Li, et al.
Process Biochemistry (2023) Vol. 128, pp. 126-136
Closed Access | Times Cited: 10
Zhihua Wang, Ye Wang, Hailiang Li, et al.
Process Biochemistry (2023) Vol. 128, pp. 126-136
Closed Access | Times Cited: 10
Calmodulin 2 expression is associated with poor prognosis in breast cancer
Ju Dong Yang, Shuixian Li, Jigang Wang, et al.
Pathology - Research and Practice (2024) Vol. 258, pp. 155326-155326
Open Access | Times Cited: 3
Ju Dong Yang, Shuixian Li, Jigang Wang, et al.
Pathology - Research and Practice (2024) Vol. 258, pp. 155326-155326
Open Access | Times Cited: 3
Integrated pan-cancer and scRNA-seq analyses identify a prognostic coagulation-related gene signature associated with tumor microenvironment in lower-grade glioma
Xuehuan Wen, Songjie Bai, Zuochun Fang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Xuehuan Wen, Songjie Bai, Zuochun Fang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
An Update on Antioxidative Stress Therapy Research for Early Brain Injury After Subarachnoid Hemorrhage
Fa Lin, Runting Li, Wen‐Jun Tu, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 23
Fa Lin, Runting Li, Wen‐Jun Tu, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 23
Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human Cancer
Jianlin Chen, G.F. Gao, Limin Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 15
Jianlin Chen, G.F. Gao, Limin Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 15
METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
Zhipeng Jiang, Wen Yin, Hecheng Zhu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 20
Zhipeng Jiang, Wen Yin, Hecheng Zhu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 20
PODNL1 Methylation Serves as a Prognostic Biomarker and Associates with Immune Cell Infiltration and Immune Checkpoint Blockade Response in Lower-Grade Glioma
Humaira Noor, Ashraf Zaman, Charles Teo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12572-12572
Open Access | Times Cited: 19
Humaira Noor, Ashraf Zaman, Charles Teo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12572-12572
Open Access | Times Cited: 19
YTH domain family: potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma
Miao Liu, Zijin Zhao, Yuan Cai, et al.
Aging (2021) Vol. 13, Iss. 21, pp. 24205-24218
Open Access | Times Cited: 18
Miao Liu, Zijin Zhao, Yuan Cai, et al.
Aging (2021) Vol. 13, Iss. 21, pp. 24205-24218
Open Access | Times Cited: 18
Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types
Ankang Hu, Yonghui Wang, Jiahao Tian, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 14
Ankang Hu, Yonghui Wang, Jiahao Tian, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 14